germacrone has been researched along with Liver-Cirrhosis* in 1 studies
1 other study(ies) available for germacrone and Liver-Cirrhosis
Article | Year |
---|---|
Co-delivery of miR-29b and germacrone based on cyclic RGD-modified nanoparticles for liver fibrosis therapy.
Hepatic stellate cells (HSCs) were activated and secreted excessive amounts of extracellular matrix (ECM) proteins during pathogenetic progress of liver fibrosis. Germacrone (GMO) and miR-29b can play an important role in inhibiting growth of HSCs and production of type I collagen. GMO and miR-29b were co-encapsulated into nanoparticles (NPs) based on poly(ethylene glycol)-block-poly(lactide-co-glycolide) (PEG-PLGA). Then, NPs were modified with cyclic RGD peptides (cRGDfK). cRGDfK is an effective ligand to bind integrin α Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Nanoparticles; Peptides, Cyclic; Sesquiterpenes, Germacrane; Tissue Distribution | 2020 |